126 related articles for article (PubMed ID: 19940667)
21. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
[TBL] [Abstract][Full Text] [Related]
22. Surgical treatment to increase the success rate of multidrug-resistant tuberculosis.
Man MA; Nicolau D
Eur J Cardiothorac Surg; 2012 Jul; 42(1):e9-12. PubMed ID: 22531273
[TBL] [Abstract][Full Text] [Related]
23. Chlamydia pneumoniae: comparison with findings of Mycoplasma pneumoniae and Streptococcus pneumoniae at thin-section CT.
Nambu A; Saito A; Araki T; Ozawa K; Hiejima Y; Akao M; Ohki Z; Yamaguchi H
Radiology; 2006 Jan; 238(1):330-8. PubMed ID: 16304082
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
25. Chest X-Ray Findings Comparison between Multi-drug-resistant Tuberculosis and Drug-sensitive Tuberculosis.
Icksan AG; Napitupulu MRS; Nawas MA; Nurwidya F
J Nat Sci Biol Med; 2018; 9(1):42-46. PubMed ID: 29456392
[TBL] [Abstract][Full Text] [Related]
26. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
[TBL] [Abstract][Full Text] [Related]
27. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
[TBL] [Abstract][Full Text] [Related]
28. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
29. CT findings in apical versus basal involvement of pulmonary tuberculosis.
Yoon JY; Lee IJ; Im HJ; Lee K; Lee Y; Bae SH
Diagn Interv Radiol; 2013; 19(2):85-90. PubMed ID: 23019057
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistance among persons with tuberculosis in California, 1994-2003.
Granich RM; Oh P; Lewis B; Porco TC; Flood J
JAMA; 2005 Jun; 293(22):2732-9. PubMed ID: 15941802
[TBL] [Abstract][Full Text] [Related]
31. [The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province].
Sun YN; Wang GJ; Zhen XA; Liu ZF; Harley D; Hall G; Vally H; Sleigh A
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):133-6. PubMed ID: 23751466
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-alpha and interleukin-10 in whole blood is associated with disease progression in pulmonary multidrug-resistant tuberculosis patients.
Eum SY; Jeon BY; Min JH; Kim SC; Cho S; Park SK; Cho SN
Respiration; 2008; 76(3):331-7. PubMed ID: 18212516
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS
Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066
[TBL] [Abstract][Full Text] [Related]
34. SLC11A1 (formerly NRAMP1) polymorphisms associated with multidrug-resistant tuberculosis.
Takahashi K; Hasegawa Y; Abe T; Yamamoto T; Nakashima K; Imaizumi K; Shimokata K
Tuberculosis (Edinb); 2008 Jan; 88(1):52-7. PubMed ID: 17950034
[TBL] [Abstract][Full Text] [Related]
35. Changes in treatment outcomes of multidrug-resistant tuberculosis.
Kwak N; Kim HR; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2015 May; 19(5):525-30. PubMed ID: 25868019
[TBL] [Abstract][Full Text] [Related]
36. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
[TBL] [Abstract][Full Text] [Related]
37. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis.
Kang YA; Kim SY; Jo KW; Kim HJ; Park SK; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Kim DY; Shim TS
Respiration; 2013; 86(6):472-8. PubMed ID: 23689646
[TBL] [Abstract][Full Text] [Related]
38. Radiologic manifestations of pulmonary tuberculosis in patients of intensive care units.
Hashemian SM; Tabarsi P; Karam MB; Kahkouee S; Marjani M; Jamaati H; Shekarchi N; Mohajerani SA; Velayati AA
Int J Mycobacteriol; 2015 Sep; 4(3):233-8. PubMed ID: 27649871
[TBL] [Abstract][Full Text] [Related]
39. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
[TBL] [Abstract][Full Text] [Related]
40. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
